Atlas Trials

Characterization of the Long-term Safety, Efficacy, and Pharmacodynamics Revestive® in the Management of Short Bowel Syndrome Pediatric Patients

Clinical trial NCT03562130 · COMPLETED

Trial details

NCT number
NCT03562130
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Short Bowel Syndrome
Start date
2018-07-02
Primary completion
2019-12-11
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.